Looking Beyond FDA Warning Letters to Explore Unforeseen Trouble Spots in eDTCA: A Response to Recent Commentaries.
Division of Communication, University of Wisconsin-Stevens Point, Stevens Point, WI, USA.
Hyosun
H
Kim
D015709:Correspondence as Topic; D004348:Drug Labeling; D033161:Government Regulation; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
Int J Health Policy Manag. 2016 Jan 16;5(3):211-3
26927597
Int J Health Policy Manag. 2015 Aug 25;4(12):813-21
26673465
Int J Health Policy Manag. 2016 Feb 10;5(4):287-8
27239875
Int J Health Policy Manag. 2016 Feb 03;5(4):271-4
27239871
Int J Health Policy Manag. 2016 Feb 18;5(5):329-31
27239883
Int J Health Policy Manag. 2016 Mar 26;5(6):391-2
27285519
JAMA. 2011 Feb 23;305(8):824-5
21343583
Int J Health Policy Manag. 2016 Feb 09;5(4):283-5
27239874
Int J Health Policy Manag. 2016 Feb 21;5(5):333-5
27239884